{"DataElement":{"publicId":"3010917","version":"1","preferredName":"Neuronal Ceroid Lipofuscinosis Diagnosis Batten Disease Type","preferredDefinition":"A description of the neuronal ceroid lipofuscinosis batten disease diagnosis.","longName":"3004978v1.0:3010913v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3004978","version":"1","preferredName":"Neuronal Ceroid Lipofuscinosis Diagnosis","preferredDefinition":"A group of mostly autosomal recessive inherited neurodegenerative disorders characterized by accumulation of lipofuscin in the neuronal cells and in other tissues including liver, spleen, kidneys, and myocardium. Signs and symptoms include motor disturbances and cognitive decline._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"3188464v1.0:2239981v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3188464","version":"1","preferredName":"Neuronal Ceroid Lipofuscinosis","preferredDefinition":"A group of mostly autosomal recessive inherited neurodegenerative disorders characterized by accumulation of lipofuscin in the neuronal cells and in other tissues including liver, spleen, kidneys, and myocardium. Signs and symptoms include motor disturbances and cognitive decline.","longName":"C61257","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuronal Ceroid Lipofuscinosis","conceptCode":"C61257","definition":"A group of mostly autosomal recessive inherited neurodegenerative disorders characterized by accumulation of lipofuscin in the neuronal cells and in other tissues including liver, spleen, kidneys, and myocardium. Signs and symptoms include motor disturbances and cognitive decline.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B65FB6B-6779-B4F1-E040-BB89AD4323E4","latestVersionIndicator":"Yes","beginDate":"2011-02-03","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-02-03","modifiedBy":"ONEDATA","dateModified":"2011-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E550547-18B0-00B1-E040-BB89AD435E51","latestVersionIndicator":"Yes","beginDate":"2010-01-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-01-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3010913","version":"1","preferredName":"Batten Disease Type","preferredDefinition":"A rare, often fatal, inherited neurodegenerative disorder characterized by the accumulation of lipopigments in the body. It is manifested in childhood. Signs and symptoms include progressive vision loss, progressive motor skills deterioration, mental impairment, and seizures._Type; a subdivision of a particular kind of thing.","longName":"3010913v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"92","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Neuronal ceroid lipofuscinosis enzyme - NCL 1 (infantile): PPT-palmitoyl protein thiosterase","valueDescription":"Infantile Neuronal Ceroid Lipofuscinosis","ValueMeaning":{"publicId":"3010915","version":"1","preferredName":"Infantile Neuronal Ceroid Lipofuscinosis","longName":"3010915","preferredDefinition":"A very rare form of neuronal ceroid lipofuscinosis inherited in an autosomal recessive pattern.  During the first six to eighteen months of life development is normal.  Subsequently, patients develop developmental abnormalities in speech and motor skills, blindness, epilepsy, and seizures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuronal Ceroid Lipofuscinosis Type 1","conceptCode":"C85861","definition":"A condition associated with mutation(s) in the PPT1 gene, encoding palmitoyl-protein thioesterase 1. The condition is one of a group of genetically heterogeneous neurodegenerative disorders, characterized by accumulation of intracellular lipopigments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC58647-700C-72A6-E040-BB89AD434C42","latestVersionIndicator":"Yes","beginDate":"2010-02-16","endDate":null,"createdBy":"WHITES","dateCreated":"2010-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A456F0F-59C1-C3F5-E040-BB89AD431521","beginDate":"2010-02-16","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-06-30","modifiedBy":"ONEDATA","dateModified":"2010-06-30","deletedIndicator":"No"},{"value":"Neuronal ceroid lipofuscinosis enzyme - NCL 2 (classic late infantile); transpeptidase","valueDescription":"Late Infantile Neuronal Ceroid Lipofuscinosis","ValueMeaning":{"publicId":"3010914","version":"1","preferredName":"Late Infantile Neuronal Ceroid Lipofuscinosis","longName":"3010914","preferredDefinition":"Infantile neuronal ceroid lipofuscinosis in which the signs and symptoms appear later in life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuronal Ceroid Lipofuscinosis Type 2","conceptCode":"C85864","definition":"A condition associated with mutation(s) in the TPP1 gene, encoding tripeptidyl-peptidase- 1. The condition is one of a group of genetically heterogeneous neurodegenerative disorders, characterized by accumulation of intracellular lipopigments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC58647-6FE7-72A6-E040-BB89AD434C42","latestVersionIndicator":"Yes","beginDate":"2010-02-16","endDate":null,"createdBy":"WHITES","dateCreated":"2010-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A456F0F-59D5-C3F5-E040-BB89AD431521","beginDate":"2010-02-16","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-06-30","modifiedBy":"ONEDATA","dateModified":"2010-06-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3115793","version":"1","preferredName":"Batten Disease Type","preferredDefinition":"A rare, often fatal, inherited neurodegenerative disorder characterized by the accumulation of lipopigments in the body. It is manifested in childhood. Signs and symptoms include progressive vision loss, progressive motor skills deterioration, mental impairment, and seizures.:Type; a subdivision of a particular kind of thing.","longName":"C61258:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuronal Ceroid Lipofuscinosis Type 3","conceptCode":"C61258","definition":"A condition associated with mutation(s) in the CLN3 gene, encoding battenin. The condition is one of a group of genetically heterogeneous neurodegenerative disorders, characterized by accumulation of intracellular lipopigments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A456F0F-59A0-C3F5-E040-BB89AD431521","latestVersionIndicator":"Yes","beginDate":"2010-06-30","endDate":null,"createdBy":"NYCHM","dateCreated":"2010-06-30","modifiedBy":"ONEDATA","dateModified":"2010-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC58647-6FCF-72A6-E040-BB89AD434C42","latestVersionIndicator":"Yes","beginDate":"2010-02-16","endDate":null,"createdBy":"WHITES","dateCreated":"2010-02-16","modifiedBy":"KUMMEROA","dateModified":"2012-04-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the type of Batten di","type":"Preferred Question Text","description":"What is the type of Batten disease?","url":null,"context":"NHLBI"},{"name":"Specify the disease subtype:","type":"Alternate Question Text","description":"Specify the disease subtype:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3010917","type":"BRIDG Mapping Path","description":"PerformedDiagnosis [first] > AssessedResultRelationship > PerformedObservation > PerformedDiagnosis.value [second] WHERE PerformedDiagnosis.value [first] = \"Batten Disease\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FC58647-7036-72A6-E040-BB89AD434C42","latestVersionIndicator":"Yes","beginDate":"2010-02-16","endDate":null,"createdBy":"WHITES","dateCreated":"2010-02-16","modifiedBy":"KUMMEROA","dateModified":"2021-08-24","changeDescription":". 2021-8-24 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}